Emerging issues and trends in attention deficit hyperactivity disorder: An update for the speech-language pathologist

Seminars in Speech and Language

Volumn 25, Issue 3, 2004, Pages 207-214

  Damico, Jack S ^a   Tetnowski, John A ^a   Nettleton, Sandra K ^b  

^a UNIVERSITY OF LOUISIANA AT LAFAYETTE   (United States)

^b Albuquerque Public Schools   (United States)

Author keywords

ADHD; Medication; Theory; Trends

Indexed keywords

ATTENTION DEFICIT DISORDER; HUMAN; PREVALENCE; PSYCHOLOGICAL MODEL; REVIEW; SPEECH DISORDER;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; MODELS, PSYCHOLOGICAL; PREVALENCE; SPEECH-LANGUAGE PATHOLOGY;

EID: 21644469220     PISSN: 07340478     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-833668     Document Type: Article

References (54)

1. Augustine L, Damico JS. Attention deficit hyperactivity disorder: the scope of the problem. Semin Speech Lang 1995;16:243-258
2. Volkmar FR. Changing perspectives on ADHD. Am J Psychiatry 2003;160:1025-1027
3. Lord J, Paisley S. The Clinical Effectiveness and Cost Effectiveness of Methylphenidate for Hyperactivity in Childhood, Version 2. London: National Institute for Clinical Excellence; 2000
4. Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am 2000;9:541-555
5. Clegg J, Hartshorne M. Speech and language therapy in hyperactivity: a United Kingdom perspective in complex cases. Semin Speech Lang 2004;25:263-270
6. Swanson JM, Sergeant JA, Taylor E, et al. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998;351:429-433
7. Taylor E, Sergeant J, Doepfner M, et al. Clinical guidelines for hyperkinetic disorder. Eur Child Adolesc Psychiatry 1998;7:184-200
8. Jouglin C, Zwi M. FOCUS on the Use of Stimulants in Children With ADHD. Primary Evidence-Base Briefing No 1. Focus Project. London: Royal College of Psychiatrists' Research Unit; 1999
9. World Health Organization. International Classification of Diseases. New York: World Health Organization Publications; 2002
10. British Psychological Society. Attention Deficit Hyperactivity Disorder (ADHD): a Psychological Response to an Evolving Concept. Leicester, England: The British Psychological Society; 1996
11. American Speech-Language-Hearing Association. Technical Report on the Roles of Audiologists and Speech-Language Pathologists Working With Students With Attention Deficit Hyperactivity Disorder. Rockville, MD: ASHA; 1996
12. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents and adults with ADHD. J Am Acad Child Adolesc Psychiatry 1997;36:85S-121S
13. American Academy of Pediatrics. Clinical practice guideline - treatment of the child with attention deficit/hyperactivity disorder (AC0002). Pediatrics 2000;108:1033-1044
14. Brock SE. Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) in Childhood: a Review of the Literature. (ERIC Document Reproduction Service No. ED 410512), Anaheim, CA: National Association of School Psychologists; 1997
15. National Institutes of Health. Consensus statement: diagnosis and treatment of attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000;39:182-193
16. Greydanus DE. Psychopharmacology for ADHD in adolescents: quo vadis? Psychiat Times 2003; 44:48-55
17. Ingram S, Hechman I, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-term outcome. Ment Retard Dev Disord Res Rev 1999; 5:243-250
18. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998;155:493-498
19. Boyajian AE, DuPaul GJ, Handler MW, Eckert TL, McGoey KE. The use of classroom-based behavior functional analyses with preschoolers at risk for attention deficit hyperactivity disorder. School Psychol Rev 2001;30:278-293
20. Connor DF. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. J Dev Behav Pediatr 2002;23(Suppl I):S1-S9
21. Loughran SB. Agreement and stability of teacher rating scales for assessing ADHD in preschoolers. Early Child Ed J 2003;30:247-253
22. Armstrong MB, Nettleton S. Attention deficit/ hyperactivity disorder and preschool children. Semin Speech Lang 2004;25:225-232
23. Pierce CD, Reid R. Attention deficit hyperactivity disorder: assessment and treament of children from culturally different groups. Semin Speech Lang 2004;25:233-240
24. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997;36(Suppl 10):85S-121S
25. Jerrell JM. Are assessment and treatment influenced by ethnicity and gender? Psychiat Times 2003;44:71-74
26. Ridley CR, Li LC, Hill CL. Multicultural assessment: reexamination, reconceptualization, and practical application. Couns Psychol 1998;26: 827-910
27. Damico JS, Muller N, Ball MJ. Owning up to complexity: a sociocultural orientation to attention deficit hyperactivity disorder. Semin Speech Lang 2004;25:277-284
28. Barkley RA. ADHD and the Nature of Self-Control. New York: Guilford Press; 1997
29. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94
30. Damico JS, Damico SK, Armstrong MB. Attention-deficit hyperactivity disorder and communicative disorders. Child Adol Psych Clinics N Am 1999;8:37-60
31. Westby CE, Cutler SK. Language and ADHD: understanding the bases and treatment of self-regulatory deficits. Top Lang Disord 1994;14:58-76
32. Westby C, Watson S. Perspectives on attention deficit hyperactivity disorder: executive functions, working memory, and language disabilities. Semin Speech Lang 2004;25:241-254
33. Dunaway C. Attention deficit hyperactivity disorder: an authentic story in the schools and its implications. Semin Speech Lang 2004;25:271-276
34. Nelson R, Hawley H. Inner control as an operational mechanism in attention deficit hyperactivity disorder. Semin Speech Lang 2004;25:255-262
35. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999;35:503-512
36. Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder. Safety, efficacy, and longterm outcome. Pediatr Drugs 2003;5:787-794
37. Kollins SH, Barkley RA, DuPaul GJ. Use and management of medications for children diagnosed with attention deficit/hyperactivity disorder (ADHD). Focus Except Child 2001;33:1-24
38. Popper CW. Pharmacological alternatives to psychostimulants for the treatment of attention deficit/hyperactivity disorder. Child Adol Psych Clinics of N Am 2002;9:605-646
39. Zito JM, Safer DJ, dos Reis S, et al. Trends in the prescribing of psychotropic medication to preschoolers. JAMA 2000;283:1025-1030
40. Accardo PA, Blondis TA. What's all the fuss about Ritalin? J Pediatr 2001;138:6-9
41. DeBar LL, Lynch F, Powell J, Gate J. Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med 2003;157:150-157
42. McGoey KE, Eckert TL, DuPaul G. Early intervention for preschool-age children with ADHD: a literature review. J Emot Behav Disord 2002;10: 14-28
43. Rappley MD, Mullen PB, Alvarez FJ, et al. Diagnosis of attention-deficit/ hyperactivity disorder and use of psychotropic medication in very young children. Arch Pediatr Adolesc Med 1999; 153:1039-1045
44. Barkley RA. Attention-Deficit Hyperactivity Disorder: a Handbook for Diagnosis and Treatment, 2nd ed. New York: Guilford Press; 1998
45. Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in treatment of children, adolescent, and adults. J Am Acad Child Adolesc Psychiatry 2002;41(Suppl 2):26S-49S
46. Greydanus DE, Patel DR. Sports doping in the adolescent athlete: the hope, hype, and hyperbole. Pediatr Clin North Am 2002;49:829-855
47. Greydanus DE, Sloane MA, Rappley MD. Psychopharmacology of ADHD in adolescents. Adolesc Med 2002;13:599-624
48. Schachter HM, Pham B, Mng J, et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents: a meta-analysis. Can Med Assoc J 2001;165:1475-1488
49. Solanto MV, Arnsten AFT, Castellanos FX. The neuroscience of stimulant drug action in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, eds. Stimulant Drugs and ADHD: Basic and Clinical Neuroscience Oxford: Oxford University Press; 2001:355-379
50. Eli Lilly and Company. Package insert: Strattera. Indianapolis, IN: Eli Lilly; 2002
51. MTA Cooperative Group. 14-month randomized clinical trial of treatment strategies for attention- deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-1086
52. Carey WB. What the multimodal treatment study of children with ADHD did and did not say about the use of methylphenidate for attention deficits. Pediatrics 2000;105:863-864
53. Pelham WE. The NIMH multimodal treatment study for attention deficit hyperactivity disorder: just say yes to drugs alone? Can J Psychiatry 1999; 44:981-990
54. Tetnowski JA. Attention deficit hyperactivity disorder and concomitant communicative disorders. Semin Speech Lang 2004;25:215-224